Summit Therapeutics
SMMT
#1300
Rank
S$18.45 B
Marketcap
$25.03
Share price
-6.90%
Change (1 day)
840.25%
Change (1 year)

Summit Therapeutics (SMMT) - Cash on Hand

Cash on Hand as of September 2024 : S$0.65 Billion

According to Summit Therapeutics 's latest financial reports the company has S$0.65 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Summit Therapeutics - Cash on Hand chart (from 2020 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.24 B-47.37%
2022-12-31S$0.46 B381.52%
2021-12-31S$97.05 M10.46%
2020-12-31S$87.86 M
2019-01-31S$62.2 M17.74%
2018-01-31S$52.83 M-15.15%
2017-01-31S$62.26 M32.2%
2016-01-31S$47.1 M36.44%
2015-01-31S$34.52 M390.27%
2014-01-31S$7.04 M-32.43%
2013-01-31S$10.42 M61.86%
2012-01-31S$6.43 M-38.57%
2011-01-31S$10.48 M-52.14%
2010-01-31S$21.89 M159.61%
2009-01-31S$8.43 M-85.09%
2008-01-31S$56.58 M-47.69%
2007-01-31S$0.10 B66.11%
2006-01-31S$65.11 M-20.78%
2005-01-31S$82.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.61 B 146.13%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.32 B-49.86%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.13 B-79.94%๐Ÿ‡บ๐Ÿ‡ธ USA